CELLphenomics is a thriving place to work. We are boosting preclinical research with more than 230 PD3D® cell cultures & a broad spectrum of cell-based assays.
“#Sequencing alone has proved remarkably unhelpful. And the belief that sequencing your DNA is going to extend your life is a cruel illusion,”
says Christian Regenbrecht, CEO of CPO @cellphenomics in Berlin. https://t.co/XoByy5dTPs
Tumortherapie: Campusfirma ASC Oncology testet anhand individueller #Tumor-Organoide bereits vor einer Therapie, welche #Medikamente wirksam sind. Lesen Sie hier das #Interview mit den Geschäftsführern Dr. Christian Regenbrecht & Quirin Graf Adelmann v. A. https://t.co/WLYF4ry3SR
Why "bomb the immune system back to the Stone Age" when you can find out exactly which treatment is most likely to work by using innovative 3D models beforehand? Christian Regenbrecht of @cellphenomics discusses the "Brave New World of 3D #Oncology."
https://t.co/4AKwuRec9m
A truly personalized approach: A researcher and the husband of a #breastcancer patient discuss how a meeting in Copenhagen led to a promising treatment, selected via 3D patient-derived cell models & the #DigiWest system. @cellphenomics#TNBC
https://t.co/mCLNvMjok6